Abraxis Oncology offers their product, Abraxane, to those who are eligible for their patient assistance program. Providers may call toll free: 1-800-564-0216
Allos Therapeutics, Inc. sponsors the Allos Support for Assisting Patients (ASAP) program, a reimbursement support and patient assistance program designed to help providers and patients gain appropriate access to Folotyn (pralatrexate injection). If you have questions, call 877-272-7102.
Amgen Assist™ gives patients and healthcare providers a single destination for access to eService and online forms, and makes it easier to find a program that would best meet each patient's unique needs. 1-800-272-9376
The Neulasta FIRST STEP™ Program is intended to provide assistance to eligible low-income patients who need help meeting their Neulasta® co-insurance or co-payment requirement
The Safety Net Foundation is a nonprofit patient assistance program that helps qualifying uninsured patients access Amgen medicines at no cost. Phone 1-888-762-6436, Main Fax 1-877-727-2867
Nexavar REACH Program, a patient assistance program provided by Bayer HealthCare Pharmaceuticals, offers Nexavar at no cost to those who are eligible for the program. 1866-639-2827
The Destination Access Patient Assistance Programs provide eligible patients with certain BMS products at no charge. Program eligibility criteria vary by product. Products include BiCNU, CeeNU, Etopophos, Lysodren, Vumon, Yervoy, Sprycel, Erbitux and Ixempra.
Please contact Destination Access at 1-800-861-0048, Monday through Friday, 8:00 AM to 8:00 PM ET.
The PSC link is a dedicated central point of contact for healthcare providers, patients and caregivers. It is a great resource for reimbursement and co-pay assistance.
At Cephalon Oncology, we go further to support patients and healthcare providers. CORE (Cephalon Oncology Reimbursement Expertise) is a convenient reimbursement resource that provides a support program along with online tools to help make it easier to understand the reimbursement process. Phone 1866-261-7730
The Eisai PAP provides Eisai medicines at no cost to financially needy patients who meet program eligibility criteria. Products include Aloxi, Dacogen, Fragmin, Gliadel Wafer, Halaven, Hexalen Capsules, Ontak and Targretin
Phone: 1-866-61-EISAI (1-866-613-4724)
Fax: 1-866-57-EISAI (1-866-573-4724)
Monday - Friday 8AM - 8PM ET
Health insurance coverage and reimbursement issues can be confusing and challenging. Genentech Access Solutions is here to make the process as easy as possible.
The customer support page of www.oncotypedx.com where a link for the GAP email address is. Phone 1-866-662-6897, Local Contact Diane Schulte 866-648-9935, Rebecca Ginther 888-817-5208
The operating companies of Johnson & Johnson have a long-standing commitment to helping patients access medicines. The operating companies of Johnson & Johnson donate free prescription medicines to the Johnson & Johnson Patient Assistance Foundation (JJPAF). JJPAF is an independent, private non-profit organization that assists patients without financial resources and prescription coverage to obtain free prescription products donated by the Johnson & Johnson operating companies. Products include Doxil, Procrit and Zytiga.
To learn more about the Foundation patient assistance programs or to apply for assistance, please visit our website jjpaf.org or call and speak to one of our Program Specialists at 866-317-2775.
PatientOne is the Lilly Oncology program that addresses financial, access, and claim issues for patients who are candidates for Lilly's Oncology products. Phone 1-866-472-8663
ACT is a 2-part program designed to assist insured patients with reimbursement issues and to provide product support for qualified individuals lacking coverage. Merck Co-Pay Assistance Program
Patient support 1-866-363-6379, Fax 1-866-363-6389
Millennium is committed to helping secure access to VELCADE® (bortezomib) for Injection for patients who have been prescribed VELCADE and have financial difficulties. Phone 1-866-835-2233
Through the Reimbursement Hotline, Novartis Oncology is dedicated to answering your questions and providing assistance with the reimbursement process for Novartis products. Phone for Zomea, Femara, Gleevec, Tasigna 1-800-282-7630, Phone for Sandostatin LAR 1-877-527-4357, Phone for Exjade 1-888-903-7277
Pfizer First Resource is a comprehensive reimbursement and patient assistance program designed to help patients gain access to the medicines they need. The program helps patients with reimbursement support, including appeals, and—in some cases—alternate funding assistance
The Roche Oncoline Patient Assistance Program offers assistance to patients who have no prescription coverage or have reached their cap and meet specific income guidelines. 1-800-443-6676
Patient assistance program, Benefit verification and prior authorization, Claims management/Appeals assistance, coding & billing guidance. Phone 1-800-996-6626, Fax 1-800-996-6627
SeaGen Secure is a comprehensive reimbursement support hotline and patient assistance program for ADCETRISTM (brentuximab vedotin). Patient assistance is available to uninsured and underinsured patients that have been prescribed ADCETRIS. Eligibility for patient assistance is based on gross family household income, residency and diagnosis. Additional program services include Benefit Investigations, assistance with underpaid/denied claims, ADCETRIS policy information and alternate funding research.
Please contact SeaGen Secure at 855.473.2436, Option 1 or www.SeaGenSecure.com to obtain an enrollment form or for additional information.
The CancerCare Co-Payment Assistance Foundation is a not-for-profit organization established in 2007 to address the needs of individuals who cannot afford their insurance co-payments to cover the cost of medications for treating cancer.
The Chronic Disease Fund is an independent 501(c)(3) non-profit charitable organization that helps underinsured patients with chronic disease, cancers or life-altering conditions obtain the expensive medications they need. We assist patients who meet income qualification guidelines and have private insurance or a Medicare Part D plan but cannot afford the co-payments for their specialty therapeutics. We pay the patient’s out-of-pocket costs directly to the provider, eliminating the cash flow problems that can prevent them from getting their medications.
The Partnership for Prescription Assistance brings together America's pharmaceutical companies, doctors, other health care providers, patient advocacy organizations and community groups to help qualifying patients who lack prescription coverage get the medicines they need through the public or private program that's right for them
Patient Access Network (PAN) Foundation is an independent, not-for-profit established in 2004, dedicated to assisting patients who cannot afford the out-of-pocket costs associated with their treatment needs. With 20 disease-specific funds, PAN assists the underinsured in accessing health care treatments. Throughout all 50 states and three U.S. territories PAN provides trained case managers that patients or advocates may speak with about their care.
The Patient Advocate Foundation (PAF) Co-Pay Relief Program (CPR) currently provides direct financial support to insured patients, including Medicare Part D beneficiaries, who must financially and medically qualify to access pharmaceutical co-payment assistance. The program offers personal service to all patients through the use of call counselors; personally guiding patients through the enrollment process.
For nearly two decades, PSI has helped people who live with certain chronic illnesses or conditions locate suitable health insurance coverage and access ways to satisfy expensive co-payments. PSI provides assistance with the cost of health insurance premiums associated with COBRAs, State High Risk Pools, Open enrollment, Guaranteed Issue policies, HIPAA conversion policies; and prescriptions co-payments associated with private insurance as well as with Medicare Parts B and D.
Corporate Angel Network is a charitable organization in the USA whose sole mission is to ease the emotional stress, physical discomfort and financial burden of travel for cancer patients by arranging FREE flights to treatment centers, using the empty seats on corporate aircraft flying on routine bussiness.
Eligibility to participate in this program is open to all cancer patients, bone marrow donors, and bone marrow recipients who are ambulatory and not in need of medical support while traveling. Eligibility is not based on financial need, and patients may travel as often as necessary.
The HealthWell Foundation® is a 501(c)(3) non-profit, charitable organization that helps individuals afford prescription medications they are taking for specific illnesses. The Foundation provides financial assistance to eligible patients to cover certain out-of-pocket health care costs
The National Organization for Rare Disorders (NORD), a 501(c)3 organization, is a unique federation of voluntary health organizations dedicated to helping people with rare "orphan" diseases and assisting the organizations that serve them. NORD is committed to the identification, treatment, and cure of rare disorders through programs of education, advocacy, research, and service.
United Way addresses pressing health and healthcare issues facing communities across the country. Community by community, United Ways and their partners target childhood obesity, health insurance coverage, healthcare quality, childhood immunizations, substance abuse, family violence, oral health or other healthcare concerns voiced by their community.
The Department of Health and Human Services is the federal government's principal agency for protecting the health of all Americans and providing essential human services, especially for those who are least able to help themselves.
Eldercare links those who need assistance with state and local area agencies on aging and community-based organizations that serve older adults and their caregivers. Whether an older person needs help with services such as meals, home care or transportation, or a caregiver needs training and education or a well-deserved break from caregiving responsibilities, the Eldercare Locator is there to point that person in the right direction.
The National Cancer Institute coordinates the National Cancer Program, which conducts and supports research, training, health information dissemination, and other programs with respect to the cause, diagnosis, prevention, and treatment of cancer, rehabilitation from cancer, and the continuing care of cancer patients and the families of cancer patients.
The Supplemental Security Income (SSI) program pays benefits to disabled adults and children who have limited income and resources. SSI benefits also are payable to people 65 and older without disabilities who meet the financial limits.